Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01171183Phase 2Completed
Phase 2, randomised, double-blind trial in cocaine dependence comparing Carvedilol with Placebo (2 arms). Primary endpoint: Urine Toxicology Screens at 10 weeks. Started Aug 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01171183.